Member Info for HaleSpur

Only Dan can save us. Riddell obviously wasn’t cut out for finding a CEO or Taking us forward so hope he enjoys his new role.
Doesn’t look good but I will have to see it out until the end.

If you don’t laugh you would cry as I had a decent profit at one point few years ago. Will keep this quiet from the mrs Incase it can turn around by a miracle :)

Agree its not over for NXP002 but the timeline is getting longer and longer and the hopes of somebody taking a punt on it is drifting.
My hope as with Olderandwiser is that NXP004 becomes something that can easily be sold to the market this year and we are not reliant on NXP002 due to the wait required for the CRO and reformulation.

Anyone seen any companies get sold off on their second in line product after failure in the first .

It's a shame Anne left when she did, she probably had the contacts and the acumen to move to a different CRO and obtain the results required sooner.
I hope we go full tilt on NXP004 now before we have time to even bother with NXP002.

FB is this not just about listing Cellcube on the main market or US. Not BMN

Obviously we have a vested interest so hopefully the UK listing happens quickly and we can finally see the energy side kick off.

Almost feels like the CRO stuffed up and then tried to get the study completed as quickly as possible.
Lanstead were probably hoping for better!

Suppose it all rides on NXP004 if there is anything to happen before Christmas. Could be losing a decent wad of cash in this, as it has the feelings of a dying company.

Fortune said it is funded by a third-party to demonstrate its investment potential, so there won't be any details on their end.
They will continue to pay the same or less than current electricity rates.... with the current energy crisis you'd hope a lot less.

From Floyds court case link : Seems BMN have been wanting to help the SP last year by immediate Enerox listing but prevented.
Mr Otto by email replied to Mr Prince in a little detail concerning the conversation with Mr Greenberg. His reply included the following:
Page 29
George Bompas QC
APPROVED JUDGMENT Garnet Commerce Ltd v VRFB Holdings Ltd Mikhail peppered them with questions on routes to go public
immediately and received the following responses
- Enerox does not look ready yet
- Enerox is too small for the US SPAC market right now - Any listing process will take 4-6 months minimum
- Cash shells in Canada / UK will achieve a listing but won't get exposure to the market valuation frenzie that is happening in the US right now, will still take 4-6 months
- You only get one shot at listing; listing in Canada / UK provides a market price, you can't subsequently try to list in the US and achieve a higher valuation
- Listing a portion of Enerox by having a cash shell buy a minority stake in Enerox would be much worse than staying private; locking in a listed market price at a valuation that reflects a company that is not ready to be public
- Even if there is a market correction, a 50% pull back in valuations still implies ridiculously high valuations; don't worry about timing just get the process right
- Market demand will remain strong; energy transition is not going to stop, it's still got years left to accelerate
The broker pitched that a private placement financing should be pursued. They offered to help on the raise, saying they know a number ofpartiesthatwouldbeinterested.Subsequenttocompletingtheprivate placement financing they offered to work with Enerox to see if the story can be evolved to something that would be a better fit for the US SPAC market.
I think Mikhail knows these realities, he's just under tremendous pressure from Fortune to do what Fortune wants (a listing so Fortune's friends can participate and allow him to keep control / gain majority control of the company).

Is it that Cellcube/Enerox are listing on the main market via RTO?
Regardless this will provide a valuation for some of the BE element, which has been at zero for many years.

Fingers crossed AV knows what's coming and does not offload any shares for a long time.

I'm with ForFX - no point taking a 5 figure loss for taking a few grand out if it makes no major difference in your bank balance. The game is still in play at the moment.
The plus side might mean a 6 figure gain if sold for £100m's etc which does happen in pharma.
If you invest in biotech you have to be ready to risk losing it all to become lucky for those 1 in 10 successes.

Didn’t you only buy shares in April, why are you complaining now. You watched a lot of that drop and put in orders a couple of times.
Either you believe in the company or you don’t but sounds a bit fishy your smelly chat.

Bloodninja Tesla was nearly bankrupt until an 11th hour funding many years to become the most valuable auto-company.
Amazon has seen 80-90 percent drops in its early years too.
Sometimes you just have to accept the share price does not follow the end game story if you have the heart for it.

We all hope the end game is close but hopefully not for single digit pennies.

Ignore me about kibo bidding for any tenders they aren’t the required company I thought. Excitement on holiday.
Was still thinking do we need another big Chinese partner to deliver the VRFBs for Eskom - like Rongke?

Holy Moly- there you potentially have the partnership to deliver grid-scale storage for Eskom.
Anyone know if Kibo bid for storage tenders?

Taz many of us have been here more than 3 years and it has been a bit of shower really. With the majority of small cap biotechs you have A 10 percent chance of winning and the other 90 percent of having your pants pulled down. You look at SNG/ODX and I could at least say I feel more confident of making something here than there, even though they have had a great lockdown.
It’s all unpredictable and could fly or fail on the toss of a coin and if you haven’t got the heart on penny biotechs then don’t do buy it.

I bought some on Monday as I looked at whether the business is profitable at these levels and is the share price undervalued. That’s my take as the markets are going to be red for a while.
Unfortunately most people don’t have the patience even for kiln 3, electrolyte plant or q2 news which should be positive.
Times are hard so there is a market sell off regardless of which share, so you have to think rationally on vanadium demand, expansion and energy storage.
This share isn’t for trading for sure!